ATE240749T1 - Radioaktivmarkierte annexin-galaktose konjugate - Google Patents

Radioaktivmarkierte annexin-galaktose konjugate

Info

Publication number
ATE240749T1
ATE240749T1 AT95923885T AT95923885T ATE240749T1 AT E240749 T1 ATE240749 T1 AT E240749T1 AT 95923885 T AT95923885 T AT 95923885T AT 95923885 T AT95923885 T AT 95923885T AT E240749 T1 ATE240749 T1 AT E240749T1
Authority
AT
Austria
Prior art keywords
radioactive labeled
labeled annexin
conjugates
galactose conjugates
galactose
Prior art date
Application number
AT95923885T
Other languages
English (en)
Inventor
John M Reno
Sudhakar Kasina
Original Assignee
Neorx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorx Corp filed Critical Neorx Corp
Priority claimed from PCT/US1995/007599 external-priority patent/WO1995034315A1/en
Application granted granted Critical
Publication of ATE240749T1 publication Critical patent/ATE240749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT95923885T 1994-06-16 1995-06-13 Radioaktivmarkierte annexin-galaktose konjugate ATE240749T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26106494A 1994-06-16 1994-06-16
PCT/US1995/007599 WO1995034315A1 (en) 1994-06-16 1995-06-13 Radiolabeled annexin-galactose conjugates

Publications (1)

Publication Number Publication Date
ATE240749T1 true ATE240749T1 (de) 2003-06-15

Family

ID=22991800

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95923885T ATE240749T1 (de) 1994-06-16 1995-06-13 Radioaktivmarkierte annexin-galaktose konjugate

Country Status (4)

Country Link
EP (1) EP1364964A1 (de)
AT (1) ATE240749T1 (de)
CA (1) CA2185349C (de)
DE (1) DE69530841T2 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010815D1 (de) * 1989-12-27 1998-04-23 Boehringer Ingelheim Int Verwendung eines antikoagulant als diagnostikum
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
CA2086437A1 (en) * 1991-05-09 1992-11-10 Jonathan Tait Phospholipid-targeted thrombolytic agents
US6323313B1 (en) * 1999-06-01 2001-11-27 The University Of Washington Annexin derivative with endogenous chelation sites
US6843980B2 (en) * 2001-04-03 2005-01-18 Theseus Imaging, Corp. Methods for using annexin for detecting cell death in vivo and treating associated conditions

Also Published As

Publication number Publication date
DE69530841D1 (de) 2003-06-26
DE69530841T2 (de) 2004-05-06
EP1364964A1 (de) 2003-11-26
CA2185349A1 (en) 1995-12-21
CA2185349C (en) 2010-04-20

Similar Documents

Publication Publication Date Title
ATE261317T1 (de) Radioaktiv markierte annexine
NO931631D0 (no) Kompleksdannende midler og maalsoeking av radioaktive immunoreagenser nyttige innen terapeutiske og diagnostiske bildedannende sammensetninger og fremgangsmetoder
DE69102600D1 (de) Diffusionsschweissrepariertechnik.
DE69711686D1 (de) Molybdänkomplexe enthaltende schmiermittelzusammensetzungen
DE69007311D1 (de) Konjugate.
DE69114050D1 (de) Kugelgelenk für Prothese.
DE3854283D1 (de) Direkt-abbildendes monochromatisches Elektronenmikroskop.
FR2660546B1 (fr) Module de reconstruction cotylouidienne.
BR9600133A (pt) Composição de organossiloxano curável
FI950346A7 (fi) Menetelmä tioeetterikonjugaattien valmistamiseksi
ATE237366T1 (de) Radioaktiv-markierte annexine
DE69108092D1 (de) Elektronenstrahlschweissen.
CA2206274A1 (en) Radiolabeled annexin-galactose cluster conjugates
DE69110750D1 (de) Zytotoxisches Testverfahren.
DE69110918D1 (de) Elektronenstrahlbestrahlungsapparat.
DE69111896D1 (de) Rohrrheometer.
DE69516071D1 (de) Elektronenquelle
FI950834A0 (fi) Poistettavissa oleva merkintäkoostumus
DE69530841D1 (de) Radioaktivmarkierte annexin-galaktose konjugate
DE59004921D1 (de) Spannvorrichtung.
FI913819A0 (fi) Immunogena konjugat av icke-toxisk oligosackarid fraon bordetella pertussis -lipo-oligosackarider.
NO881635D0 (no) Vinylsubstituerte radioaktive halogenkonjugater for proteinmerking.
ZA967037B (en) Composition for an artificial track.
DE69516052D1 (de) Röntgenstrahlenquelle
EP0440168A3 (en) One-part curable organosiloxane composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties